Starting in his role as Project Manager, Dejan brings extensive experience in site creation and over a decade of experience in the production of radiopharmaceuticals. As the lead in key projects, Dejan will be responsible for the finalization of our newly built production site and provide support in the production of Terbium-161 GMP.

“I’m really grateful and excited to take on this challenge and looking forward to helping bring the Tb161 production site to completion. What makes it even more special is the chance to reunite with colleagues with whom I’ve already shared great successes in the past. I can’t wait to achieve new milestones together!” said Dejan Čatlaić, Project Manager at TerThera b.v.

TerThera B.V. has officially launched the world’s first GMP-compliant Terbium-161 NCA, setting a new benchmark in the commercial scale production of this promising radionuclide.

Milestone reached. With the extended geographical reach, we were able to meet the demand for Terbium-161 (Tb-161) on 6 continents by ramping up the production that has led to reaching the threshold 200Ci or 7.4TBq Terbium-161 produced and expedited.